DTCFF (Defence Therapeutics) Tax Rate %: 0.00% (As of Mar. 2026)


DTCFF Defence Therapeutics Inc DTCFF
25 GF Score
Price $0.32
! 1 Warning Sign
View Full Analysis

What is Defence Therapeutics Tax Rate %?

Defence Therapeutics DTCFF -2.44% 25 Tax Rate % is 0.00% as of Mar. 2026. GuruFocus rates DTCFF with a GF Score™ of 25/100. The stock has 1 warning sign investors should review.

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Defence Therapeutics's Tax Expense for the three months ended in Mar. 2026 was $0.00 Mil. Defence Therapeutics's Pre-Tax Income for the three months ended in Mar. 2026 was $-2.16 Mil. Therefore, Defence Therapeutics's Tax Rate % for the quarter that ended in Mar. 2026 was 0.00%.

Defence Therapeutics Tax Rate % Related Terms

Defence Therapeutics Tax Rate % Historical Data

* Premium members only.

The historical data trend for Defence Therapeutics's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Defence Therapeutics Tax Rate % Chart

Defence Therapeutics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Tax Rate %
Get a 7-Day Free Trial 0.00 0.00 1.53 0.00 0.00

Defence Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
DTCFF
25GF Score
Defence Therapeutics Inc DTCFF
Tax Rate % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Defence Therapeutics Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Defence Therapeutics's Tax Rate % for the fiscal year that ended in Jun. 2025 is calculated as

Tax Rate %=Tax Expense (A: Jun. 2025 )/Pre-Tax Income (A: Jun. 2025 )
=0/-2.577
=0.00 %

Defence Therapeutics's Tax Rate % for the quarter that ended in Mar. 2026 is calculated as

Tax Rate %=Tax Expense (Q: Mar. 2026 )/Pre-Tax Income (Q: Mar. 2026 )
=0/-2.159
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Rate % →
What does a Tax Rate % of 0.00% mean?
Defence Therapeutics (DTCFF) has a Tax Rate % of 0.00% as of Mar. 2026.
Is Defence Therapeutics' Tax Rate % too high?
Defence Therapeutics' current Tax Rate % is 0.00%. Overall, Defence Therapeutics has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Defence Therapeutics' Tax Rate % compare to VRTX and REGN?
Defence Therapeutics' Tax Rate % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Rate % for a Biotechnology company?
A good Tax Rate % depends on the Biotechnology industry context. However, Tax Rate % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Rate % mean?
A high Tax Rate % can signal that a stock is expensive relative to its fundamentals. Defence Therapeutics's current Tax Rate % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Defence Therapeutics stock overvalued right now?
Defence Therapeutics (DTCFF) has a current Tax Rate % of 0.00%. The current Tax Rate % is 0.00%. Defence Therapeutics' overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Rate % calculated?
Tax Rate % is calculated from a company's financial statements. For Defence Therapeutics (DTCFF), the current Tax Rate % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Defence Therapeutics Business Description

Other Exchanges DTC:GermanyDTC:Canada
Address 7171 Frederick Banting Street, Montreal, QC, CAN, H4S 1Z9
Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development. It operates only in Canada.
25GF Score

Get the complete analysis for DTCFF

Tax Rate % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.32
Price